BioMarin Pharmaceutical Inc. (BMRN)

Growth

Revenue 5Y8.70%
Revenue 3Y6.63%
EPS 5Y13.78%
EPS 3Y5.89%
Dividend 5Y-
Dividend 3Y-

Capital Efficiency

ROIC1.88%
ROE1.89%
ROA1.34%
ROTA1.42%

Capital Structure

Market Cap21.80B
EV22.12B
Cash761.51M
Current Ratio5.15
Debt/Equity0.27
Net Debt/EBITDA1.50
Show More

Income Statement

Select a metric from the list below to chart it

Dec '98
Dec '03
Dec '08
Dec '13
Dec '18
Income Statement
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
TTM
Revenue
548.5
751.0
889.9
1,116.9
1,313.6
1,491.2
1,704.0
1,860.5
1,846.3
2,008.3
Revenue % Chg.
9.5%
36.9%
18.5%
25.5%
17.6%
13.5%
14.3%
9.2%
-0.8%
8.6%
Cost of Revenue
95.7
129.8
152.0
209.6
241.8
315.3
359.5
524.3
470.5
476.1
Cost of Revenue % Chg.
4.3%
35.5%
17.1%
37.9%
15.3%
30.4%
14.0%
45.8%
-10.3%
-0.2%
Gross Profit
452.7
621.3
737.9
907.2
1,071.9
1,175.9
1,344.6
1,336.2
1,375.8
1,532.2
Gross Profit % Chg.
10.7%
37.2%
18.8%
23.0%
18.1%
9.7%
14.3%
-0.6%
3.0%
11.7%
Gross Profit Margin
82.5%
82.7%
82.9%
81.2%
81.6%
78.9%
78.9%
71.8%
74.5%
76.3%
Gross Profit Margin % Chg.
1.1%
0.2%
0.2%
-2.0%
0.4%
-3.4%
0.1%
-9.0%
3.8%
2.8%
R&D Expenses
354.8
461.5
634.8
661.9
610.8
696.3
715.0
628.1
628.8
637.9
R&D Expenses % Chg.
17.4%
30.1%
37.5%
4.3%
-7.7%
14.0%
2.7%
-12.2%
0.1%
2.2%
Selling, General, & Admin Expenses
235.4
302.2
402.3
476.6
554.3
604.4
680.9
737.7
759.4
825.8
Selling, General, & Admin Expenses % Chg.
18.8%
28.4%
33.1%
18.5%
16.3%
9.0%
12.7%
8.3%
2.9%
12.0%
Other Expenses
18.6
18.0
-17.7
-27.0
46.5
48.8
74.1
62.2
61.9
62.7
Other Expenses % Chg.
-0.6%
-3.5%
-
52.4%
-
5.0%
51.9%
-16.1%
-0.5%
0.0%
Operating Income
-156.0
-92.9
-110.7
-803.4
-14.7
-123.5
-100.5
-36.8
-82.3
108.2
Operating Income % Chg.
41.5%
40.5%
19.2%
625.8%
98.2%
740.3%
18.7%
63.4%
124.0%
-
Operating Income Margin
-28.4%
-12.4%
-12.4%
-71.9%
-1.1%
-8.3%
-5.9%
-2.0%
-4.5%
5.4%
Operating Income Margin % Chg.
29.2%
56.5%
0.6%
478.3%
98.4%
640.2%
28.8%
66.5%
125.7%
-
Total Other Income/Expenses Net
-20.5
-32.0
-44.0
-27.6
-21.2
-19.2
5.6
-5.6
7.0
-7.6
Total Other Income/Expenses Net % Chg.
154.2%
56.0%
37.7%
37.3%
23.3%
9.4%
-
-
-
-
Income Before Tax
-176.5
-124.9
-154.7
-831.1
-35.9
-142.7
-94.8
-42.3
-75.4
100.6
Income Before Tax % Chg.
49.2%
29.3%
23.9%
437.1%
95.7%
297.8%
33.6%
55.4%
78.0%
-
Income Before Tax Margin
-32.2%
-16.6%
-17.4%
-74.4%
-2.7%
-9.6%
-5.6%
-2.3%
-4.1%
5.0%
Income Before Tax Margin % Chg.
36.2%
48.3%
4.6%
328.0%
96.3%
250.4%
41.9%
59.1%
79.4%
-
Income Tax Expense
-0.2
9.1
17.1
-200.8
81.2
-65.5
-71.0
-901.4
-11.3
16.6
Income Tax Expense % Chg.
96.2%
-
87.6%
-
-
-
8.4%
1170.3%
98.7%
-
Net Income
-176.4
-134.0
-171.8
-630.2
-117.0
-77.2
-23.8
859.1
-64.1
83.9
Net Income % Chg.
54.2%
24.0%
28.2%
266.8%
81.4%
34.0%
69.1%
-
-
427.2%
Net Income Margin
-32.2%
-17.8%
-19.3%
-56.4%
-8.9%
-5.2%
-1.4%
46.2%
-3.5%
4.2%
Net Income Margin % Chg.
40.8%
44.5%
8.2%
192.3%
84.2%
41.9%
73.0%
-
-
385.3%
Weighted Avg. Shares Out
137.8
146.3
160.0
166.0
174.4
177.1
179.0
180.8
180.8
184.6
Weighted Avg. Shares Out % Chg.
14.5%
6.2%
9.3%
3.7%
5.1%
1.5%
1.1%
1.0%
-
1.3%
EPS
-1.3
-0.9
-1.1
-3.8
-0.7
-0.4
-0.1
4.8
-0.4
0.5
EPS % Chg.
34.7%
28.1%
16.3%
255.1%
82.4%
34.3%
70.5%
-
-
400.0%
Weighted Avg. Shares Out Dil
137.8
146.3
160.0
166.2
174.4
177.3
179.0
191.7
191.7
187.9
Weighted Avg. Shares Out Dil % Chg.
14.5%
6.2%
9.3%
3.9%
4.9%
1.6%
1.0%
7.1%
-
1.9%
EPS Diluted
-1.3
-0.9
-1.1
-3.8
-0.7
-0.4
-0.1
4.5
-0.3
0.4
EPS Diluted % Chg.
34.7%
28.1%
16.3%
256.1%
82.4%
34.3%
70.5%
-
-
425.0%
Interest Income
3.1
5.9
4.5
7.5
14.9
22.8
22.7
16.6
10.5
11.1
Interest Income % Chg.
19.3%
92.6%
-24.2%
66.3%
98.4%
53.7%
-0.4%
-27.0%
-36.9%
-6.3%
Interest Expense
10.4
33.3
35.0
36.1
39.0
40.1
21.4
29.3
14.7
15.6
Interest Expense % Chg.
36.8%
218.8%
4.9%
3.4%
7.9%
2.7%
-46.5%
36.8%
-49.7%
-3.1%
EBIT
-183.9
-152.2
-185.2
-859.7
-60.0
-159.9
-93.5
-55.0
-79.6
96.0
EBIT % Chg.
49.1%
17.2%
21.6%
364.3%
93.0%
166.5%
41.5%
41.1%
44.7%
-
EBIT Margin
-33.5%
-20.3%
-20.8%
-77.0%
-4.6%
-10.7%
-5.5%
-3.0%
-4.3%
4.8%
EBIT Margin % Chg.
36.1%
39.5%
2.7%
269.9%
94.1%
134.8%
48.8%
46.1%
45.8%
-
Depreciation & Amortization
47.3
56.7
47.2
96.9
87.9
95.7
105.3
105.2
108.0
103.4
Depreciation & Amortization % Chg.
4.3%
20.1%
-16.8%
105.4%
-9.3%
8.9%
10.1%
-0.1%
2.7%
-5.5%
EBITDA
-136.6
-95.5
-138.0
-762.8
27.9
-64.3
11.8
50.2
28.4
199.4
EBITDA % Chg.
75.0%
30.1%
44.5%
452.8%
-
-
-
324.7%
-43.3%
255.1%
EBITDA Margin
-24.9%
-12.7%
-15.5%
-68.3%
2.1%
-4.3%
0.7%
2.7%
1.5%
9.9%
EBITDA Margin % Chg.
59.8%
48.9%
21.9%
340.5%
-
-
-
289.0%
-42.9%
226.8%